Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Comparative Study

Clinical Trial

Multicenter Study

Review

Clinical Trial, Phase III

Observational Study

Meta-Analysis

Systematic Review

Letter

Research Support, N.I.H., Extramural

Case Reports

Clinical Trial Protocol

Publication Year

From

Quick links

Individual year

2025

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Insulin, Isophane""[mesh_terms]

65 Results

Searching titles within these results

Practical approach to management of inpatient hyperglycemia in select patient populations.

Boris Draznin, Cecilia C Low Wang

Hospital practice (1995) 2013;41(2):45-53

Full Text

Abstract

Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.

Guillermo E Umpierrez, Sidney Jones, Dawn Smiley, Patrick Mulligan, Trevor Keyler, Angel Temponi, Crispin Semakula, Denise Umpierrez, Limin Peng, Miguel Cerón, Gonzalo Robalino

Diabetes care 2009;32(7):1164-9

Free Full Text

Abstract

Comparing the efficacy and safety of insulin detemir versus neutral protamine hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study.

Jing Ji, Zhangya He, Zhao Yang, Yang Mi, Na Guo, Hong Zhao, Jiayi Gao, Zhengfeei Ma, Xiaoqin Luo, Zhen Han

BMJ open diabetes research & care 2021;8(1):e001155

Free Full Text

Abstract

Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.

Tim Heise, Chantal Mathieu

Diabetes, obesity & metabolism 2017;19(1):3-12

Free Full Text

Abstract

A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).

Alison Lunsford, Mark D Wheeler, Margarita Barrientos-Perez, Fu-Sung Lo, Bo Liang, Ólöf Thórisdóttir, Nehama Zuckerman-Levin

European journal of pediatrics 2018;177(10):1497-1503

Free Full Text

Abstract

Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.

D R Owens, G B Bolli

Diabetes technology & therapeutics 2008;10(5):333-49

Full Text

Abstract

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.

J Rosenstock, V Fonseca, J B McGill, M Riddle, J P Hallé, I Hramiak, P Johnston, M Davis

Diabetologia 2010;52(9):1971-3

Free Full Text

Insulin and oral agents for managing cystic fibrosis-related diabetes.

Adrienne Stolfi, Gary M Onady

The Cochrane database of systematic reviews 2016;4():CD004730

Full Text

Abstract

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.

D Khutsoane, S K Sharma, M Almustafa, H C Jang, S T Azar, R Danciulescu, M Shestakova, N M A Ayad, S Guler, O M Bech

Diabetes, obesity & metabolism 2008;10(3):212-22

Full Text

Abstract

Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study.

V Cherubini, B Pintaudi, M C Rossi, G Lucisano, F Pellegrini, G Chiumello, A P Frongia, C Monciotti, I P Patera, S Toni, S Zucchini, A Nicolucci

Nutrition, metabolism, and cardiovascular diseases : NMCD 2014;24(5):538-46

Full Text

Abstract

Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

D R Owens, P A Coates, S D Luzio, J P Tinbergen, R Kurzhals

Diabetes care 2000;23(6):813-9

Full Text

Abstract

Early use of neutral Protamine Hagedorn (NPH) insulin in the management of diabetic ketoacidosis: an open-label randomized controlled trial in a resource-limited setting.

Naveen Baby, Mukta Wyawahare, Dukhabandhu Naik, Nishaant Ramasamy

BMC research notes 2025;18(1):471

Free Full Text

Abstract

Basal insulin analogs: from pathophysiology to therapy. What we see, know, and try to comprehend?

C Colette, D Owens, L Monnier

Diabetes & metabolism 2014;39(6):468-76

Full Text

Abstract

Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with Type 1 diabetes.

D Santoro, L Scarpa, P Bates, D Valle

Diabetes, nutrition & metabolism 2001;14(3):126-32

Full Text

Abstract

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.

P Valensi, M Benroubi, V Borzi, J Gumprecht, R Kawamori, J Shaban, S Shah, M Shestakova, Y Wenying

International journal of clinical practice 2009;63(3):522-31

Full Text

Abstract

Results: 1 – 15 / 65

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Insulin, Isophane""[mesh_terms]

Practical approach to management of inpatient hyperglycemia in select patient populations.

Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.

Comparing the efficacy and safety of insulin detemir versus neutral protamine hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study.

Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.

A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).

Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.

Insulin and oral agents for managing cystic fibrosis-related diabetes.

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.

Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study.

Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

Early use of neutral Protamine Hagedorn (NPH) insulin in the management of diabetic ketoacidosis: an open-label randomized controlled trial in a resource-limited setting.

Basal insulin analogs: from pathophysiology to therapy. What we see, know, and try to comprehend?

Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with Type 1 diabetes.

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.

Results for
""Insulin, Isophane""[mesh_terms]